Chen B - Search Results

1

Comparative analysis of the efficacy of different treatments for idiopathic membranous nephropathy: a retrospectively real-world study.

Sun M, Huang J, Dong J, Li Z, Li C, Zhang S, Chen B. Sun M, et al. Among authors: chen b. Curr Med Res Opin. 2023 May;39(5):761-769. doi: 10.1080/03007995.2023.2192608. Epub 2023 Apr 3. Curr Med Res Opin. 2023. PMID: 36938631

2

Clinical and pathological features of idiopathic membranous nephropathy with focal segmental sclerosis.

Li J, Chen B, Gao C, Huang J, Wang Y, Zhang S, Xu Y, Guo W, Wang R. Li J, et al. Among authors: chen b. BMC Nephrol. 2019 Dec 16;20(1):467. doi: 10.1186/s12882-019-1641-2. BMC Nephrol. 2019. PMID: 31842785 Free PMC article.

3

Retrospective study: clinicopathological features and prognosis of idiopathic membranous nephropathy with seronegative anti-phospholipase A2 receptor antibody.

Guo W, Zhang Y, Gao C, Huang J, Li J, Wang R, Chen B. Guo W, et al. Among authors: chen b. PeerJ. 2020 Feb 21;8:e8650. doi: 10.7717/peerj.8650. eCollection 2020. PeerJ. 2020. PMID: 32117644 Free PMC article.

4

The optimal anti-phospholipase A2 receptor cutoff for the diagnosis of idiopathic membranous nephropathy: a single-center retrospective study.

Li C, Li P, Guo W, Chen L, Li J, Wang R, Chen B. Li C, et al. Among authors: chen l, chen b. Korean J Intern Med. 2022 Jan;37(1):154-166. doi: 10.3904/kjim.2020.366. Epub 2021 Jul 22. Korean J Intern Med. 2022. PMID: 32972118 Free PMC article.

5

Clinical and pathological features of anti-glomerular basement membrane disease associated with membranous nephropathy: an observational study.

Zhang S, Li C, Huang J, Zhou Y, Gao C, Sun M, Wang R, Chen B. Zhang S, et al. Among authors: chen b. Ren Fail. 2022 Dec;44(1):1904-1914. doi: 10.1080/0886022X.2022.2141645. Ren Fail. 2022. PMID: 36351876 Free PMC article.

6

Clinical characteristics and prognosis of patients with idiopathic membranous nephropathy with kidney tubulointerstitial damage.

Sun M, Li P, Dong J, Li Z, Li C, Zhang S, Chen B. Sun M, et al. Among authors: chen b. Ren Fail. 2023 Dec;45(1):2205951. doi: 10.1080/0886022X.2023.2205951. Ren Fail. 2023. PMID: 37125531 Free PMC article.

7

Efficacy and safety of rituximab for primary membranous nephropathy with different clinical presentations: a retrospective study.

Zhang S, Huang J, Dong J, Li Z, Sun M, Sun Y, Chen B. Zhang S, et al. Among authors: chen b. Front Immunol. 2023 Apr 28;14:1156470. doi: 10.3389/fimmu.2023.1156470. eCollection 2023. Front Immunol. 2023. PMID: 37187749 Free PMC article.

8

The efficacy and safety of rituximab with or without glucocorticoid in inducing remission of MCD with different clinical presentations in adults: a retrospective study.

Sun Y, Li Z, Sun J, Zhang S, Wang R, Chen B. Sun Y, et al. Among authors: chen b. Clin Kidney J. 2024 May 3;17(6):sfae139. doi: 10.1093/ckj/sfae139. eCollection 2024 Jun. Clin Kidney J. 2024. PMID: 38854425 Free PMC article.

9

Efficacy analysis of rituximab in treating patients with primary membranous nephropathy dependent on calcineurin inhibitors.

Li Z, Zhao T, Zhang S, Huang J, Wang H, Sun Y, Wang R, Chen B. Li Z, et al. Among authors: chen b. Front Immunol. 2024 Dec 18;15:1504646. doi: 10.3389/fimmu.2024.1504646. eCollection 2024. Front Immunol. 2024. PMID: 39744641 Free PMC article.

10

Effects of mycophenolate mofetil, valsartan and their combined therapy on preventing podocyte loss in early stage of diabetic nephropathy in rats.

Zhang Y, Chen B, Hou XH, Guan GJ, Liu G, Liu HY, Li XG. Zhang Y, et al. Among authors: chen b. Chin Med J (Engl). 2007 Jun 5;120(11):988-95. Chin Med J (Engl). 2007. PMID: 17624267

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29,380 results

Search Page

Filters